logo dark logo light logo
  • Home
  • About Us
    • Background
    • Investment Strategy
    • Team
  • Portfolio
  • News
  • Contact
  • 中文
  • Investor Login
mobile-logo
  • Home
  • About Us
    • Background
    • Investment Strategy
    • Team
  • Portfolio
  • News
  • Contact
  • 中文
  • Investor Login
We are Company Builders

We are Company Builders

Identifying, incubating and growing future industry leaders in life sciences.

We are Industry Veterans

We are Industry Veterans

Capturing evolving healthcare trends and emerging cutting-edge innovations

We are Preferred Partners

We are Preferred Partners

Connecting companies with extensive network and resources globally and in China

  • Tempest Announces Closing of Up To $8.35 Million Registered Direct Offering of Common Stock and Concurrent Private Placement of Warrants Priced At-the-Market Under Nasdaq Rules

    ...

    November 26, 2025
  • Avenzo Therapeutics Announces Appointment of Scott Lipman as Chief Financial Officer

    ...

    November 19, 2025
  • NextCure Announces Closing of $21.5 Million PIPE Financing in Advance of First Half 2026 Phase 1 POC Data Readouts

    ...

    November 17, 2025
All news

899 Halei Road, Building B, 4/F, Pudong New Area, Shanghai 201203, P.R. China
Phone: +86 21 6163 2598 | Fax: +86 21 6163 2570 | Email: info@quancapital.com

© Quan Capital. All rights reserved. Website Development. 沪ICP备18031693号-1